Tubal patency after clinical treatment of unruptured ectopic pregnancy.
To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. Of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management.